glucos fresenius kabi 50 mg/ ml
fresenius kabi norge as - halden - glukosemonohydrat - infusjonsvæske, oppløsning - 50 mg/ ml
glucos fresenius kabi 100 mg/ ml
fresenius kabi norge as - halden - glukosemonohydrat - infusjonsvæske, oppløsning - 100 mg/ ml
glucos fresenius kabi 200 mg/ ml
fresenius kabi norge as - halden - glukosemonohydrat - infusjonsvæske, oppløsning - 200 mg/ ml
glucos fresenius kabi 500 mg/ ml
fresenius kabi norge as - halden - glukosemonohydrat - infusjonsvæske, oppløsning - 500 mg/ ml
natriumklorid-glucos baxter viaflo 4.5 mg/ ml / 25 mg/ ml
baxter medical ab - natriumklorid / glukosemonohydrat - infusjonsvæske, oppløsning - 4.5 mg/ ml / 25 mg/ ml
natriumklorid-glucos baxter viaflo 9 mg/ ml / 50 mg/ ml
baxter as - natriumklorid / glukose - infusjonsvæske, oppløsning - 9 mg/ ml / 50 mg/ ml
rehydrex med glucos
fresenius kabi norge as - halden - glukosemonohydrat / natriumacetattrihydrat / natriumklorid - infusjonsvæske, oppløsning - 25 mg/ ml
rehydrex med glucos
fresenius kabi norge as - halden - glukosemonohydrat / natriumacetattrihydrat / natriumklorid - infusjonsvæske, oppløsning - 50 mg/ ml
paxlovid
pfizer europe ma eeig - nirmatrelvir, ritonavir - covid-19 virus infection - paxlovid is indicated for the treatment of coronavirus disease 2019 (covid-19) in adults who do not require supplemental oxygen and who are at increased risk for progressing to severe covid 19.